Cymbalta Withdrawal Litigation
Cymbalta Lawsuit History
The first case we filed against Eli Lilly and Company alleges that Eli Lilly violated consumer protection law when it omitted material information in its promotion and marketing of Cymbalta—namely, that Cymbalta causes a high percentage of consumers who attempt to stop taking it to experience withdrawal reactions (contrary to the label). That case is Strafford v. Eli Lilly & Co., Case No. 12-cv-09366 (C.D. Cal.). The Strafford case, filed on October 31, 2012, is a proposed class action lawsuit brought on behalf of Cymbalta consumers in four states (California, New York, Massachusetts, and Missouri).
Case Documents
Plaintiffs’ Notice of Motion and Motion to Set Aside Dismissals and Reopen the Case – 01/29/2018
Defendant Eli Lilly and Company’s Opposition to Plaintiffs’ Motion to Set Aside Dismissals and Reopen the Case – 02/12/2018
Plaintiffs’ Reply Brief to Defendant’s Opposition and in Support of Plaintiffs’ Motion to Reopen Case – 02/19/2018